Branding, Clinical Development and Gene Silencing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Branding

Clinical Development

Gene Silencing

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

JUNE 14, 2023

The exact cost of Vevye has not been publicly disclosed; however, it is estimated that the price of Vevye may be in the range of similar cyclosporine ophthalmic emulsions, such as brand-name Restasis that carries a list price of $645.63 One such approved medication is Miebo , an ophthalmic solution developed by Bausch + Lomb and Novaliq.

Gene Silencing

Gene Silencing Drug Delivery FDA Approval RNA

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Pharma Marketing Network

DECEMBER 21, 2020

While this narrative will undoubtedly evolve throughout the clinical development process, the first draft should be developed as early as the IND-enabling stage. This will create an early shared understanding that will provide a framework for consistent communications throughout clinical development and post launch.

Genetics

Genetics Medicine Gene Therapy Marketing

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Clinical Research Informer

Vevye: A New Cyclosporine Solution for Dry Eye Disease

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Webinars

Stay Connected